⁦The Economist⁩ published my letter to the editor: a few words responding to their special report about the future of AI in healthcare economist.com/letters/2024/0…

New episode (and it's ep. 100!) alert! Link in bio!
Dr. Cathy Eng
@MarkLewisMD
Kristen Ciombor
Mike Pishvaian
Sharlene Gill, MD, MPH, MBA, FASCO
Katrina Pedersen, MD, MS
Michael LaPelusa, MD
Tim Brown, MD MSCE
Prof Michael Jefford (he/him)
Adham Jurdi
Michael Shusterman, MD

#MedEd #MedicalEducation #Hematology #HemeOnc #Podcast #InternalMedicine

Muy contento de anunciar que a partir del próximo mes estaré uniéndome al equipo de trabajo de CU Anschutz Medical Campus en Denver como Profesor Asociado de Oncología y Director Asociado de Oncología Global. Gracias INCMNSZ por ser mi casa por 16 años. Seguiremos trabajando juntos!

We are proud to roll out our *highly anticipated* colorectal cancer series!

Today, we discuss the fundamentals, including key definitions and workup, to set you up for success!

Get ready, y'all! This series is going to be 🔥

Link in bio!

Boom. ASCO TECAG

OK, this one is really meaningful for our whole team. Our preclinical paper on pan-RAS inhibition in pancreatic cancer is now online nature. Led by OliveLab student Ula Waśko and Revolution Medicines colleagues JingJing Jiang and Mallika Singh. nature.com/articles/s4158…

#1/8 Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 (pembro) in 2L #HCC presented at #AACR2024 & published in Nature Medicine
➡️nature.com/articles/s4159…
ORR 31%,⏫historical control of pembro monotherapy (~17%)
Details below:

Honored to be the next chair of ASCO ASCOTECAG and follow in the amazing footsteps and leadership of Fernando Diaz, MD!!!

Very grateful👏🏻for all of the amazing mentors who have helped me along the way Razelle Kurzrock, MD Sumanta K. Pal, MD, FASCO Vivek Subbiah, MD Jun Gong jc gilberto lopes ❤️

This is the #Algorithm we have used during our discussion w/ Tanios Bekaii-Saab, MD for #HCC !

#OncTwitter #MedTwtitter #gism #MedEd CancerNetwork® #OncEd #LiverCancer

We congratulate the recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research, Scott Kopetz, MD, PhD.
Dr. Kopetz will present his Award Lecture at #AACR24 on Sunday April 7, 4:30-5:15 PM. Learn more: bit.ly/3TEwaSz

LISTEN NOW: Nazli Dizman shares the intricacies of her journey towards becoming an oncologist in the United States. MD Anderson Cancer Center

targetedonc.com/view/dizman-s-…

#TumorBoardTuesday Mike Pishvaian Integrity CE, LLC 1/17 #TumorBoardTuesday #OncTwitter

60yo♂️ w/no FH of🦀
😷Abd pain+biliary obstruction
🩻4cm pancreatic mass+multiple <1cm liver lesions on MRI/MRCP c/w metastases (too small to biopsy)
📈Initial CA 19-9 = 2320
✅Underwent ERCP + stent

Check out this awesome piece led by Chris Cann, MD Fox Chase Cancer Center on the under-utilization of supportive care in patients with locally advanced pancreatic cancer! Out now in ESMO - Eur. Oncology GI! sciencedirect.com/science?_ob=Ga…

How can #liquidbiopsies uniquely interpret the efficacy of novel #immunotherapy combinations in the neoadjuvant space?
Just out #openaccess in Nature Medicine
nature.com/articles/s4159…
short📽️youtu.be/6qwHLH8uTAQ

EC Action Network Johns Hopkins Thoracic Oncology Cancer Research Institute Vincent Lam

Out in Nature Medicine our phase Ib study of neoadjuvant nivo/nivo+LAG-3 + chemoRT in esoph/GEJ cancer; linking ctDNA w path/immune responses and RFS. nature.com/articles/s4159… Elsa Anagnostou Johns Hopkins Thoracic Oncology Conquer Cancer, the ASCO Foundation #esophagealcancer 1/5

.Heidi Ledford tackles an enigma that so many oncologists & researchers are grappling with:
Why are so many young people getting cancer?
nature.com/articles/d4158…
Featuring the voices of Dr. Cathy Eng S. George Barreto Kimmie Ng, MD, MPH Sonia Kupfer Shuji Ogino
There’s a new Cancer Grand Challenges

Read about our experience using serum GH as a prognostic biomarker for pts w advanced HCC treated w durva/treme! Similar to what’s previously been reported for pts treated w atezo/bev. Is targeting GH signaling next? MD Anderson Cancer Center Dove Medical Press dovepress.com/articles.php?a…

2) Border disparities; it seems appropriate that I discuss this in greater depth as both the former President and current President are visiting the border region today. One of the five priority areas identified by the president’s President Biden cancer panel #NationalCancerPlan includes,

Two new studies hint at a greater understanding of how to apply #immunotherapy in early and advanced #HCC , but also highlight complexities and gaps in this rapidly evolving field.
News & Views from David James Pinato 🇺🇦 & colleagues @ImperialCollege UPO - Università
nature.com/articles/s4159…